Commentary

Page 12

Posts about this type

Commentary

Another Point of View: Superiority, Noninferiority, and the Role of Active Comparators

October 24, 2011

Helena Chmura Kraemer

Commentary

Commentary: Dimensional Diagnosis and DSM-5

October 24, 2011

Joel Paris

Commentary

Commentary: The Problematic DSM-5 Personality Disorders Proposal: Options for Plan B

October 24, 2011

Michael B. First

Commentary

Child Murder and Mental Illness in Parents: Implications for Psychiatrists

May 15, 2011

Susan Hatters Friedman, Phillip J. Resnick

Commentary

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It

April 19, 2011

Leonard J. Paulozzi, Richard H. Weisler, Ashwin A. Patkar

Commentary

Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results

April 5, 2011

H. George Nurnberg

Commentary

The Current Crisis of Confidence in Antidepressants

January 15, 2011

Commentary

Clozapine: More Side Effects but Still the Best Antipsychotic

August 15, 2010

Xin Kang, George M. Simpson

Commentary

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

July 13, 2010

Andrew C. Leon

Commentary

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

November 15, 2009

Joseph F. Goldberg

Commentary

Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications

June 15, 2009

Jan A. Fawcett, Ross J. Baldessarini, William H. Coryell, et al

Commentary

Maintenance of Certification in Psychiatry

May 13, 2009

Michael H. Ebert, Larry Faulkner, Dorothy E. Stubbe, et al

Commentary

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

April 15, 2009

Anthony P. Weiss, Jenny Guidi, Maurizio Fava

Commentary

COMMENTARY: Diagnosing and Managing Complicated ADHD

June 16, 2008

Robert L. Findling, L. Eugene Arnold, Laurence L. Greenhill, et al

Commentary

Psychosis and Agitation in Dementia: Should General Psychiatrists Care?

March 14, 2008

Pierre N. Tariot

Commentary

High-Dose Olanzapine for Treatment-Resistant Schizophrenia

February 14, 2008

Bryan L. Roth

Commentary

COMMENTARY: The Challenge of Managing Families With Intimate Partner Violence in Primary Care

December 15, 2007

Therese Zink

Commentary

Diagnosing and Managing Complicated ADHD

December 14, 2007

Robert L. Findling, L. Eugene Arnold, Laurence L. Greenhill, et al

Commentary

On Clinicians' Professional Difficulties

August 15, 2007

Frank V. deGruy

Commentary

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

August 15, 2007

Madelaine M. Wohlreich, Curtis G. Wiltse, Durisala Desaiah, et al

Commentary

Medication Use, Service Utilization, and Medical Costs Associated With New Episodes of Bipolar Disorder: Evidence From a Retrospective Claims Database

August 15, 2007

Robert L. Ohsfeldt, Maureen J. Lage, Krithika Rajagopalan

Commentary

The Patient-Physician Relationship and Medical Utilization

August 15, 2007

Denis J. Lynch, Angele V. McGrady, Rollin W. Nagel, et al

Commentary

The Revised Black Box Warning for Antidepressants Sets a Public Health Experiment in Motion

July 16, 2007

Andrew C. Leon

Commentary

A Whole New World: Complexity Theory and Mood Variability in Mental Disorders

June 15, 2007

Michael S. Klinkman

« 1 … 10 11 12 13 14 »

Commentary

Another Point of View: Superiority, Noninferiority, and the Role of Active Comparators

Commentary: Dimensional Diagnosis and DSM-5

Commentary: The Problematic DSM-5 Personality Disorders Proposal: Options for Plan B

Child Murder and Mental Illness in Parents: Implications for Psychiatrists

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It

Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results

The Current Crisis of Confidence in Antidepressants

Clozapine: More Side Effects but Still the Best Antipsychotic

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications

Maintenance of Certification in Psychiatry

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

COMMENTARY: Diagnosing and Managing Complicated ADHD

Psychosis and Agitation in Dementia: Should General Psychiatrists Care?

High-Dose Olanzapine for Treatment-Resistant Schizophrenia

COMMENTARY: The Challenge of Managing Families With Intimate Partner Violence in Primary Care

Diagnosing and Managing Complicated ADHD

On Clinicians' Professional Difficulties

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

Medication Use, Service Utilization, and Medical Costs Associated With New Episodes of Bipolar Disorder: Evidence From a Retrospective Claims Database

The Patient-Physician Relationship and Medical Utilization

The Revised Black Box Warning for Antidepressants Sets a Public Health Experiment in Motion

A Whole New World: Complexity Theory and Mood Variability in Mental Disorders

ELSEWHERE:

FOLLOW US:

Commentary

Posts about this type

Another Point of View: Superiority, Noninferiority, and the Role of Active Comparators

Commentary: Dimensional Diagnosis and DSM-5

Commentary: The Problematic DSM-5 Personality Disorders Proposal: Options for Plan B

Child Murder and Mental Illness in Parents: Implications for Psychiatrists

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It

Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results

The Current Crisis of Confidence in Antidepressants

Clozapine: More Side Effects but Still the Best Antipsychotic

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications

Maintenance of Certification in Psychiatry

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

COMMENTARY: Diagnosing and Managing Complicated ADHD

Psychosis and Agitation in Dementia: Should General Psychiatrists Care?

High-Dose Olanzapine for Treatment-Resistant Schizophrenia

COMMENTARY: The Challenge of Managing Families With Intimate Partner Violence in Primary Care

Diagnosing and Managing Complicated ADHD

On Clinicians' Professional Difficulties

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

Medication Use, Service Utilization, and Medical Costs Associated With New Episodes of Bipolar Disorder: Evidence From a Retrospective Claims Database

The Patient-Physician Relationship and Medical Utilization

The Revised Black Box Warning for Antidepressants Sets a Public Health Experiment in Motion

A Whole New World: Complexity Theory and Mood Variability in Mental Disorders

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles